drugset / Trial / NCT00754832

American Ginseng Treatment for Multiple Sclerosis Related Fatigue

NCT00754832 ↗

RandomizedCrossoverQuadruple-blindTreatment

Summary

This research project will determine the safety and tolerability of ginseng in subjects with MS and will gather preliminary data on the efficacy of ginseng vs placebo for the treatment of MS fatigue.

Timeline

Start
2005-09
Primary completion
2008-09
Completion
2011-03

Outcome

Missed primary endpoint

paper fatigue on ginseng, as assessed by the Fatigue Severity Scale, was not significantly different from fatigue on placebo. PMID 21803872 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject GINSENG, AMERICAN Unknown 400 mg Oral

Indications